Columbus, OH

Surgery isn’t a typical treatment for multiple myeloma. But in some cases, surgery may be necessary to address complications from the disease. Multiple myeloma is a rare type of cancer that causes abnormal cells to develop in your bone marrow. As multiple myeloma spreads, it can lead to bone damage or loss.

The Role of Surgery in Treating Multiple Myeloma

Axios

Brain cancer research produced by a Duke scientist who's spent more than six decades at the university helped a drug receive FDA approval this week. Why it matters: The approval is the first major advancement in low-grade brain cancer treatment in more than two decades, according to the news outlet Fierce Pharma.

Duke research leads to a new brain cancer treatment getting FDA approval

After receiving cancer treatment and leaving the hospital, sometimes it feels like a safety net has been pulled away and loneliness sets in. I’m taking “pen to paper” to journal about something I am currently experiencing. This is slightly embarrassing to share, but I believe that some...

Experiencing Loneliness as a Cancer Survivor

Healthline

R-ICE is a treatment for non-Hodgkin's and Hodgkin's lymphoma. It combines four chemotherapy drugs that kill cancer cells and is often used prior to a stem cell transplant. Learn more.

What Is the R-ICE Chemotherapy Protocol?

Through colon cancer and liver cancer, faith is what brought me to peace and clarity during treatment and now survivorship. Cancer is a word that strikes fear into the hearts of many. It conjures images of suffering, loss and a battle that often feels unwinnable. For me, cancer wasn’t just a distant concept; it was my reality. My journey with cancer was a rollercoaster of emotions, faith and, ultimately, a testament to the power of surrendering to God.

Surrendering to God: How My Faith Led to Healing From Cancer

Reuters

(Reuters) - Servier Pharmaceuticals said on Tuesday the U.S. Food and Drug administration has approved the French drugmaker's treatment for a type of brain tumor, making it the first drug to get a U.S. approval for the condition.

US FDA approves Servier's brain tumor treatment

A second dendritic cell vaccine has received fast track designation from the Food and Drug Administration. The Food and Drug Administration (FDA) has granted a fast track designation to a dendritic cell vaccine for the treatment of patients with pancreatic ductal adenocarcinoma. Immuno-oncology company Diakonos Oncology Corporation announced the designation...

FDA Fast Tracks Pancreatic Cancer Vaccine

The FDA has approved denileukin diftitox-cxdl for relapsed/refractory cutaneous T-cell lymphoma after at least 1 prior systemic therapy. The FDA has approved denileukin diftitox-cxdl (Lymphir) for the treatment of patients with relapsed/refractory cutaneous T-cell lymphoma (CTCL) after at least 1 prior systemic therapy.1. The approval was supported by data from...

FDA Approves Denileukin Diftitox for R/R Cutaneous T-Cell Lymphoma

Community Voices represent independent, third-party users who have joined our contributor program but not yet verified their accounts. Community Voices are expected, like all users, to adhere to our Community Standards.

community_voice

Herbie J Pilato

He was a charismatic cross between big-screen legends Clark Gable and Gary Cooper, and small-screen music icon Ricky Nelson, but somehow Chad Everett, best known as Dr. Joe Gannon from classic TV's Medical Center (CBS, 1969-1976), never became the superstar he should have.

The Charismatic Life and Career and Tragic Death of TV's 'Medical Center' Star Chad Everett

Offering patients with concussion a type of brain scan known as diffusion tensor imaging MRI could help identify the one in three people who will experience persistent symptoms that can be life changing, say Cambridge researchers. Around one in 200 people in Europe every year will suffer concussion. In the...

One-Third of Concussion Patients Diagnosed With "Hidden Disease" Using Advanced MRI

Tackling brain cancer is complicated, but groundbreaking new research could help add another tool to the cancer-fighting arsenal. A team from Georgia Tech and Virginia Tech published a paper in APL Bioengineering in May that explores a new option that could one day be used to target glioblastoma, a deadly and fast-growing brain tumor.

Veterinary Researchers Help Find New technique could help treat aggressive brain tumors

Summary: Diality received FDA 510(k) clearance for its Moda-flx Hemodialysis System, which aims to enhance kidney disease treatment with customizable features and improved usability. This system supports various dialysis treatments and is designed to reduce the burden of care for patients and providers in multiple care settings. Key Takeaways:. FDA...

Diality Receives FDA Clearance for Moda-flx Hemodialysis System

SurvivorNet

An international clinical trial, conducted by Swiss healthcare company Roche to study a drug to help children with a rare genetic developmental disorder called dup15q syndrome, has been cancelled—prompting heartbreak among families in hopes of finding a life-changing medication for their loved ones.

Families Heartbroken After Clinical Trial Studying Drug To Help Children With Rare Genetic Disorder Is Canceled

The Lens

This year’s area of low oxygen in the Gulf of Mexico is larger than average, the National Oceanic and Atmospheric Administration (NOAA) announced on Thursday. The “dead zone” is approximately 6,705 square miles , as measured last week. Within NOAA’s 38 years of measuring the dead zone, this year’s assessment marks the 12th-largest area of low to no oxygen, which can kill fish and marine life.

Gulf ‘dead zone’ larger than average, larger than expected for 2024, scientists announce

From Patti Yasutake’s death from cancer to Olympic water polo player’s husband’s rare cancer diagnosis, here’s what’s happening in the oncology space this week. “Star Trek” actress died of cancer. Patti Yasutake, known for her roles as Nurse Alyssa Ogawa from the “Star Trek”...

‘Star Trek’ Actress Dies of Cancer, Olympian Reveals Husband’s Cancer and More

Kansas State

Writers represent independent, third-party users who have joined our contributor program and self-verified their accounts. Writers are expected, like all users, to adhere to our Community Standards.

writer

Missouri State

CJ Coombs

National Center for Missing and Exploited Children (NCMEC) helps to locate missing children. Since July 1, 2024, according to the National Center for Missing and Exploited Children (NCMEC), 174 children have been reported missing in the U.S. Since January 1, 2024, there was a total of 1,445 reported missing in the country.

Missing Missouri children as of July 17, 2024, according to the NCMEC

Cancer Health

FDA approves vorasidenib for Grade 2 astrocytoma or oligodendroglioma with a susceptible IDH1 or IDH2 mutation. On August 6, 2024, the Food and Drug Administration approved vorasidenib (Voranigo, Servier Pharmaceuticals LLC), an isocitrate dehydrogenase-1 (IDH1) and isocitrate dehydrogenase-2 (IDH2) inhibitor, for adult and pediatric patients 12 years and older with Grade 2 astrocytoma or oligodendroglioma with a susceptible IDH1 or IDH2 mutation, following surgery including biopsy, sub-total resection, or gross total resection.

FDA Approves New Targeted Therapy for Brain Cancer

Thyroid lymphoma is an extremely rare but highly treatable cancer that affects the thyroid gland. It can cause a mass in the neck, difficulty swallowing, and shortness of breath.

What to Know About Thyroid Lymphoma

Hamish Graham, from Littleborough, England, initially dismissed his head pain and dizziness as a migraine until he lost a significant amount of weight without trying and was overcome with tiredness— something which prompted his mom to push for him to get blood work done. He was ultimately diagnosed with leukemia.

23-Year-Old Working at Movie Theatre Dismissed His Weight Loss & Dizziness As Migraines, Turned Out To Be Leukemia

In 2006, Diana Lindsay, who had never so much as held a cigarette, was diagnosed with stage 4 lung cancer. It had metastasized to both lungs, her brain and lymph nodes. Keith Eaton, MD, PhD, clinical director of thoracic, head and neck medical oncology at Fred Hutch Cancer Center, told her that a typical patient in this situation would have about nine months to live. But he also observed that she seemed remarkably strong and vital. “He said, ‘You don’t look like my normal lung cancer patient,’” said Lindsay, who had just returned from a business trip to Europe. She was 54 at the time. “He didn’t want to take away the health I had for the limited time I had to live.”

20 Years Since an EGFR Discovery, a Woman With Stage IV Lung Cancer Is Thriving

NewsBreak

Informed Consent from Patients With Glioblastoma Is a ‘Big Thing’

For patients with glioblastoma, collecting information about their disease and treatment options is important before providing informed consent. Cognitive impairments, such as a lack of short-term...

Informed Consent from Patients With Glioblastoma Is a ‘Big Thing’

Comments / 0